Liberty Health Sciences (OTCMKTS:LHSIF) Shares Down 2.2% – Should You Sell?

Liberty Health Sciences Inc. (OTCMKTS:LHSIF)’s stock price was down 2.2% during mid-day trading on Monday . The stock traded as low as $1.10 and last traded at $1.1446. Approximately 671,400 shares changed hands during trading, a decline of 60% from the average daily volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Price Performance

The firm’s fifty day moving average price is $1.14 and its two-hundred day moving average price is $1.14. The stock has a market cap of $392.01 million, a P/E ratio of 38.17 and a beta of 1.70.

About Liberty Health Sciences

Liberty Health Sciences, trading on the OTC Markets under the symbol LHSIF, is a vertically integrated medical cannabis company headquartered in Florida. The company holds state‐issued Medical Marijuana Treatment Center licenses that authorize cultivation, processing and retail operations within Florida’s regulated medical marijuana program. Its state‐of‐the‐art cultivation facilities feature controlled indoor and greenhouse environments designed to produce consistent, high‐quality flower and derivative products.

Liberty Health Sciences markets its products under the Sunshine Cannabis Co brand, offering a range of cannabis formulations that include dried flower, pre-rolled joints, concentrates, oils, capsules and topical preparations.